On January 3, 2023, Shanghai Biotree BIOTECH Co., Ltd., a leading Chinese metabolomics research company, announced the completion of a strategic financing round of CNY 10 Million A+.

Roche Diagnostics China and Beijing Hotgene Biotechnology Co., Ltd. have reached a cooperation to jointly launch the novel coronavirus (2019-nCoV) antigenic detection kit on the basis of fully integrating the advantages of technology and resources of both sides.

Guangzhou MyGene Medical Technology Co., Ltd. announced the completion of several hundred million yuan in Series C financing. This round of financing was led by Efung Capital, the funds will be used for R&D and product registration for the IVD products.

Following the broader life science tools space, proteomics firms experienced something of a retrenchment in 2022 as the boom times of the previous two years gave way to layoffs, strategic realignments, and delays.

Recently, Chengdu Qi Tan Technology Co., Ltd. announced that it had completed the financing round C of 700 million CNY. This round of financing was led by Mei Tuan Capital, and the Capital Great Health Fund managed by HG Capital and BioTrack Capital continued to make additional investments.

Meihua Medical completes Series B financing of over CNY 100 Million, committed to building a superior brand in microbiology testing. Non-invasive cancer early screening company OneGene completes tens of millions of CNY Series B financing.

Medtronic said in October it plans to divest its patient monitoring and respiratory interventions businesses.

On September 28, a series of activities for the 110th anniversary of Peking University's Medical Education, "the Collective Signing Ceremony of the University-Enterprise Joint Research & Development Platform", was held.

Four Companies Were Financed: Ancient Times of Genomics, SysDiagno Biotechnology, Derlead Biotech, Sanyou Biopharmaceuticals

Applied DNA Sciences on Thursday priced a planned $12 million public offering of stock and warrants.